Application of Current Guidelines to the Management of Unstable Angina and Non-ST-Elevation Myocardial Infarction (Q28166001)

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Cardiology and cardiovascular medicine

30 March 2024

main subject

myocardial infarction

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

30 March 2024

1

0 references

language of work or name

English

0 references

publication date

21 October 2003

0 references

full work available at URL

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000086952.14979.32

file format

Portable Document Format

online access status

open access

1 reference

Europe PubMed Central

PubMed ID

14605017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605017

http://intl-circ.ahajournals.org/cgi/content/abstract/108/16_suppl_1/III28

30 March 2024

online access status

open access

1 reference

Europe PubMed Central

PubMed ID

14605017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605017

https://www.ahajournals.org/doi/full/10.1161/01.CIR.0000086952.14979.32

30 March 2024

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

30 March 2024

0 references

108

0 references

page(s)

III28-37

0 references

issue

16 Suppl 1

0 references

cites work

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G

5

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

30 March 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification

30 March 2024

8

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Atypical presentations among medicare beneficiaries with unstable angina pectoris**This material was prepared by the Alabama Quality Assurance Foundation under a contract with the Centers for Medicare and Medicaid Services (CMS). Contents do not nece

30 March 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Representation of elderly persons and women in published randomized trials of acute coronary syndromes

30 March 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia

30 March 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients

30 March 2024

12

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

30 March 2024

14

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

30 March 2024

15

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

30 March 2024

16

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups

30 March 2024

17

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry

30 March 2024

18

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Identification of patients at high risk for death and cardiac ischemic events after hospital discharge

30 March 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

30 March 2024

20

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRIS

30 March 2024

21

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial).

30 March 2024

22

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction

30 March 2024

23

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

30 March 2024

25

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy

30 March 2024

26

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

30 March 2024

28

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

30 March 2024

29

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy

30 March 2024

30

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

30 March 2024

31

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Early and late effects of clopidogrel in patients with acute coronary syndromes

30 March 2024

32

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Is CURE a cure for acute coronary syndromes? Statistical versus clinical significance

30 March 2024

33

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting

30 March 2024

34

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

30 March 2024

35

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

30 March 2024

36

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

30 March 2024

37

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

30 March 2024

38

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention

30 March 2024

40

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

30 March 2024

41

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Low–molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus*

30 March 2024

44

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

30 March 2024

45

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

The SYNERGY trial: study design and rationale

30 March 2024

46

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

30 March 2024

47

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Enoxaparin versus tinzaparin in non-ST-segment elevation acute coronary syndromes: the EVET trial

30 March 2024

48

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study

30 March 2024

50

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy

30 March 2024

51

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

30 March 2024

52

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease

30 March 2024

53

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Invasive vs conservative management of acute coronary syndromes: do the data support the guidelines?

30 March 2024

54

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina

30 March 2024

55

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

30 March 2024

56

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry.

30 March 2024

57

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction.

30 March 2024

58

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Benefit of an early invasive management strategy in women with acute coronary syndromes

30 March 2024

59

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

30 March 2024

60

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Acute coronary syndromes: does sex matter?

30 March 2024

61

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Women do have an improved long-term outcome after non-ST-elevation acute coronary syndromes treated very early and predominantly with percutaneous coronary intervention: a prospective study in 1,450 consecutive patients

30 March 2024

62

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary Article

30 March 2024

63

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

30 March 2024

64

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Early statin treatment following acute myocardial infarction and 1-year survival

30 March 2024

65

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Early statin initiation and outcomes in patients with acute coronary syndromes

30 March 2024

66

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Estimating treatment effects from observational data: dissonant and resonant notes from the SYMPHONY trials

30 March 2024

67

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

30 March 2024

68

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial

30 March 2024

69

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

30 March 2024

70

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

30 March 2024

71

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Withdrawal of statins increases event rates in patients with acute coronary syndromes

30 March 2024

73

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

30 March 2024

74

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000086952.14979.32

30 March 2024

Identifiers